CD44 and prostate cancer: Moreover, forced expression of miR-145 suppressed tumour sphere formation and expression of CSC markers and ‘stemness’ factors, including CD133, CD44, Oct4, c-Myc and Klf4 in prostate cancer cells, and inhibited bone invasion and tumourigenesis of prostate cancer in vivo163.